Literature DB >> 24120585

Improving the management and outcome in haemolytic disease of the foetus and newborn.

Enrico Lopriore1, Mirjam E A Rath1, Helen Liley2, Vivianne E H J Smits-Wintjens1.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24120585      PMCID： PMC3827389          DOI： 10.2450/2013.0147-13

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  29 in total

Review 1.  Overview of the state of the art of Rh disease: history, current clinical management, and recent progress.

Authors:  J A Stockman
Journal:  J Pediatr Hematol Oncol       Date:  2001 Aug-Sep       Impact factor: 1.289

Review 2.  Thirty-five years of Rh prophylaxis.

Authors:  John Bowman
Journal:  Transfusion       Date:  2003-12       Impact factor: 3.157

Review 3.  Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn.

Authors:  R Gottstein; R W I Cooke
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-01       Impact factor: 5.747

4.  Combined intravascular-intraperitoneal transfusions in hydropic twins due to Rh (D) alloimmunization.

Authors:  J Santolaya; S L Warsof
Journal:  Fetal Diagn Ther       Date:  1990       Impact factor: 2.587

5.  Comparison of four types of intrauterine transfusion: effect on fetal hematocrit.

Authors:  K J Moise; R J Carpenter; B Kirshon; R L Deter; J D Sala; L E Cano
Journal:  Fetal Ther       Date:  1989

6.  When to perform the next intra-uterine transfusion in patients with Rh allo-immunization: combined intravascular and intraperitoneal transfusion allows longer intervals.

Authors:  U Nicolini; N K Kochenour; P Greco; E Letsky; C H Rodeck
Journal:  Fetal Ther       Date:  1989

7.  Effect of direct fetal opioid analgesia on fetal hormonal and hemodynamic stress response to intrauterine needling.

Authors:  N M Fisk; R Gitau; J M Teixeira; X Giannakoulopoulos; A D Cameron; V A Glover
Journal:  Anesthesiology       Date:  2001-10       Impact factor: 7.892

Review 8.  Immunoglobulin infusion for isoimmune haemolytic jaundice in neonates.

Authors:  G S Alcock; H Liley
Journal:  Cochrane Database Syst Rev       Date:  2002

9.  Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation.

Authors: 
Journal:  Pediatrics       Date:  2004-07       Impact factor: 7.124

10.  High-dose intravenous immune globulin therapy for hyperbilirubinemia caused by Rh hemolytic disease.

Authors:  J Rübo; K Albrecht; P Lasch; E Laufkötter; J Leititis; D Marsan; B Niemeyer; J Roesler; C Roll; B Roth
Journal:  J Pediatr       Date:  1992-07       Impact factor: 4.406
View more
  3 in total

1.  Exchange Transfusion for Severe Neonatal Hyperbilirubinemia: 17 Years' Experience from Vojvodina, Serbia.

Authors:  Nevenka Bujandric; Jasmina Grujic
Journal:  Indian J Hematol Blood Transfus       Date:  2015-04-02       Impact factor: 0.900

2.  The effect of extended c, E and K matching in females under 45 years of age on the incidence of transfusion-induced red blood cell alloimmunisation.

Authors:  Josine A Oud; Dorothea Evers; Masja de Haas; Karen M K de Vooght; Daan van de Kerkhof; Nel Som; Nathalie C V Péquériaux; Francisca Hudig; Arjan Albersen; Johanna G van der Bom; Jaap Jan Zwaginga
Journal:  Br J Haematol       Date:  2021-08-03       Impact factor: 8.615

3.  Intravenous Immunoglobulins as Adjunct Treatment to Phototherapy in Isoimmune Hemolytic Disease of the Newborn: A Retrospective Case-Control Study.

Authors:  Manar Al-Lawama; Eman Badran; Ala' Elrimawi; Amal Bani Mustafa; Haitham Alkhatib
Journal:  J Clin Med Res       Date:  2019-10-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.